CliffBio
small molecule

NALLPEN IN PLASTIC CONTAINER

NAFCILLIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameNALLPEN IN PLASTIC CONTAINER
Active ingredientNAFCILLIN SODIUM
StrengthEQ 2GM BASE/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1989
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.